台股 » 個股 » 台康生技 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

台康生技

(6589)
可現股當沖
  • 股價
    61.2
  • 漲跌
    ▲0.4
  • 漲幅
    +0.66%
  • 成交量
    135
  • 產業
    上櫃 生技醫療類股
  • 524人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
台康生技 (6589)籌碼相關-日進 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/0805/2406/0806/2207/0607/2008/0208/1608/3009/1409/2610/1210/2611/0811/2212/0612/2001/0401/1802/0802/2203/0603/1803/3004/1404/265055606570758085Jul '24Sep '24Nov '24Jan '25Mar '25May '2560d90dAll

日進 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/0200.00263.6063.40-2372-0.54%
2025/04/2800.00561.6062.00-5407-1.23%
2025/04/25161.4000.0061.3014120.24%
2025/04/18163.0000.0063.0014490.22%
2025/04/1500.00163.3063.50-1486-0.21%
2025/03/2100.00378.0078.30-3581-0.52%
2025/03/1400.001174.8975.60-11875-1.26%
2025/03/05178.1000.0077.8019970.10%
2025/02/2700.001079.1379.00-101,060-0.94%
2025/02/2500.001580.4680.10-151,064-1.41%
2025/02/20181.90181.7081.3001,0690.00%
2025/02/04180.5000.0081.0011,1810.08%
2025/01/22277.00277.3080.5001,2370.00%
2025/01/2100.00177.3076.30-11,231-0.08%
2025/01/2000.00281.1580.90-21,226-0.16%
2025/01/1700.00181.1081.20-11,250-0.08%
2025/01/1600.00179.3079.80-11,245-0.08%
2025/01/1500.00878.3979.00-81,241-0.64%
2025/01/1000.00177.4077.90-11,222-0.08%
2025/01/09173.8000.0075.8011,2030.08%
2025/01/0700.00173.8074.50-11,187-0.08%
2024/12/24171.8000.0070.9011,2050.08%
2024/12/23171.9000.0071.6011,2090.08%
2024/12/20171.7000.0071.7011,2330.08%
2024/12/19573.4000.0073.1051,2520.40%
2024/12/18574.0000.0074.5051,2550.40%
2024/12/13970.0200.0068.0091,1860.76%
2024/12/12273.303174.7973.50-291,110-2.61%
2024/12/111.176.3500.0076.601.11,0450.11%
2024/12/10182.9000.0082.9019450.11%
2024/12/06189.5000.0090.2019140.11%
2024/12/0400.00193.0092.30-1899-0.11%
2024/11/28192.90191.4092.1008120.00%
2024/11/25189.00189.2088.2007480.00%
2024/11/14190.6000.0089.0017380.14%
2024/11/1200.00189.0089.40-1736-0.14%
2024/11/1100.001.392.3290.70-1.3723-0.18%
2024/11/0500.00293.0094.10-2691-0.29%
2024/11/0100.000.294.3091.80-0.2680-0.03%
2024/10/25089.46289.0089.10-2594-0.33%
2024/10/1600.003.484.6185.10-3.4631-0.54%
2024/10/14083.80283.9084.40-2666-0.30%
2024/10/11084.8000.0084.5006750.00%
2024/10/09087.0000.0087.3006800.00%
2024/10/08087.5000.0087.3006860.00%
2024/10/04087.2000.0087.4007200.00%
2024/10/01488.2000.0088.4047330.55%
2024/09/2700.00287.6087.60-2766-0.26%
2024/09/24793.9100.0091.5079370.75%
2024/09/2300.000.693.4094.00-0.6937-0.06%
2024/09/18085.4000.0088.8009620.00%
2024/09/12083.0000.0083.0009920.00%
2024/09/11283.0000.0083.1021,0080.20%
2024/09/06282.3000.0082.8021,0540.19%
2024/09/04483.0300.0082.9041,2010.33%
2024/09/035.284.7500.0084.605.21,2030.43%
2024/09/02085.3000.0085.1001,2120.00%
2024/08/27084.7000.0085.0001,2230.00%
2024/08/2600.00484.6084.40-41,226-0.33%
2024/08/220.284.5000.0084.600.21,2290.02%
2024/08/21085.6000.0085.5001,2290.00%
2024/08/19084.40184.0084.00-11,223-0.08%
2024/08/14081.7000.0082.5001,2200.00%
2024/08/12282.0000.0081.1021,2280.16%
2024/08/05277.5000.0077.3021,2000.17%
2024/07/29187.5000.0085.9011,1540.09%
2024/07/26089.20289.0088.30-21,147-0.17%
2024/07/222.489.4400.0089.002.41,1440.21%
2024/07/196.191.3300.0090.506.11,1310.54%
2024/07/18293.6000.0093.4021,1180.18%
2024/07/17193.4000.0094.3011,1010.09%
2024/07/16194.7000.0092.7011,0880.09%
2024/07/15193.8000.0093.7011,0850.09%
2024/07/1200.00191.8091.20-11,068-0.09%
2024/07/11090.8000.0090.5001,0630.00%
2024/07/09390.97192.9091.3021,0840.18%
2024/07/08294.3000.0093.4021,0660.19%
2024/07/05393.17193.2093.0021,0540.19%
2024/07/04094.05294.5093.90-21,040-0.19%
2024/07/03095.6300.0094.9001,0220.00%
2024/07/022.197.792.197.2497.1009910.00%
2024/07/01595.00295.2596.5038910.34%
2024/06/28089.8000.0090.5008040.00%
2024/06/270.289.5800.0088.000.27810.02%
2024/06/261.290.9500.0090.601.27560.16%
2024/06/24286.5000.0086.1026940.29%
2024/06/12288.95185.3084.5016220.16%
2024/06/11186.0000.0086.3015420.18%
2024/05/2300.000.778.8080.10-0.7560-0.13%
2024/05/2000.00482.2882.50-4557-0.72%
〈熱門股〉台康生技美國FDA藥證申請未過 周跌逾2成Anue鉅亨-2024/12/14
台康抗癌生物相似性藥獲歐盟 CHMP 推薦 有望第4季上市UDN聯合新聞網-2023/09/18
台康生技 相關文章
台康生技 相關影音